The company plans to start assessing the effects of semaglutide, the active ingredient in Ozempic, and other medicines on alcohol consumption this month in a newly announced clinical trial in alcohol-related liver disease although cutting drinking isnt the studys main goal
Apotex commits to near-term launch "Our team is committed to bringing this product to market in the very near future," Thomas told CBC News in an email
There is variability in results
The measurement falls just above the 50-unit mark (halfway on a 1mL syringe)
If two people both lose 20 pounds, a body composition check might reveal that Person A lost mostly fat while Person B lost a mix of fat and muscle, very different outcomes for their health
Studies in patients with diabetes have shown that at the 28-week mark, people taking 1 mg of semaglutide lose approximately 7% of their weight